World Wires · story 3245 · corroborated · 1 source(s)

Next-gen glycoengineering for fine-tuning mAb galactosylation

Combining cellular and metabolic glycoengineering with 2-deoxy-2-fluorogalactose feeding in CHO cells tunes therapeutic antibody galactosylation.

Open in the desk

Coverage

• Next-gen glycoengineering for fine-tuning mAb galactosylation bioRxiv (new preprints) · tier C · clear net · 2026-09-28 00:00 UTC

What this site indexes